Literature DB >> 20566763

Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.

Shuji Uemura1, Shin-ichi Yokota, Hirotoshi Mizuno, Eiji Sakawaki, Keigo Sawamoto, Kunihiko Maekawa, Katsutoshi Tanno, Kazuhisa Mori, Yasufumi Asai, Nobuhiro Fujii.   

Abstract

Three of seven clonally related Pseudomonas aeruginosa strains isolated from a burn patient produced the extended-spectrum beta-lactamase (ESBL) SHV-12. Its gene was flanked by two IS26 elements with a large transposon (>24 kb). The transposon also contained at least five IS26 elements and a gene encoding the amikacin resistance determinant aminoglycoside 6'-N-acetyltransferase type Ib [aac(6')-Ib]. It was inserted into the gene PA5317 in the P. aeruginosa chromosome.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20566763      PMCID： PMC2934948          DOI： 10.1128/AAC.00110-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Authors:  T Naas; L Philippon; L Poirel; E Ronco; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; J Foster; J S Lam; D P Speert
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.

Authors:  Yoshinori Yamano; Toru Nishikawa; Takaji Fujimura; Takashi Yutsudou; Masakatsu Tsuji; Hideaki Miwa
Journal:  J Antibiot (Tokyo)       Date:  2006-12       Impact factor: 2.649

Review 5.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 6.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan.

Authors:  Katsutoshi Yamasaki; Masaru Komatsu; Tomonari Yamashita; Koichi Shimakawa; Toshiro Ura; Hisaaki Nishio; Kaori Satoh; Ryoudou Washidu; Shohiro Kinoshita; Masanori Aihara
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

8.  Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran.

Authors:  Freshteh Shahcheraghi; Vajiheh-Sadat Nikbin; Mohammad Mehdi Feizabadi
Journal:  Microb Drug Resist       Date:  2009-03       Impact factor: 3.431

9.  Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).

Authors:  Véronique Dubois; Corinne Arpin; Virginie Dupart; Aline Scavelli; Laure Coulange; Catherine André; Isabelle Fischer; Frédéric Grobost; Jean-Philippe Brochet; Isabelle Lagrange; Brigitte Dutilh; Jacqueline Jullin; Patrick Noury; Gilberte Larribet; Claudine Quentin
Journal:  J Antimicrob Chemother       Date:  2008-05-08       Impact factor: 5.790

10.  Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece.

Authors:  Laurent Poirel; Evangelia Lebessi; Marisa Castro; Cindy Fèvre; Maria Foustoukou; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191
View more
  5 in total

1.  Persistence and epidemic propagation of a Pseudomonas aeruginosa sequence type 235 clone harboring an IS26 composite transposon carrying the blaIMP-1 integron in Hiroshima, Japan, 2005 to 2012.

Authors:  Wataru Shimizu; Shizuo Kayama; Shuntaro Kouda; Yoshitoshi Ogura; Kanao Kobayashi; Norifumi Shigemoto; Norimitsu Shimada; Raita Yano; Junzo Hisatsune; Fuminori Kato; Tetsuya Hayashi; Taijiro Sueda; Hiroki Ohge; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

2.  Detection of SHV type Extended-Spectrum B-lactamase and Risk Factors in Pseudomonas aeruginosa Clinical Isolates.

Authors:  Nasrin Bahmani; Rashid Ramazanzadeh
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

Review 3.  A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.

Authors:  Apostolos Liakopoulos; Dik Mevius; Daniela Ceccarelli
Journal:  Front Microbiol       Date:  2016-09-05       Impact factor: 5.640

4.  Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and Tehran hospitals, Iran.

Authors:  A Peymani; T Naserpour-Farivar; E Zare; K H Azarhoosh
Journal:  J Prev Med Hyg       Date:  2017-06

5.  Transposase-DNA Complex Structures Reveal Mechanisms for Conjugative Transposition of Antibiotic Resistance.

Authors:  Anna Rubio-Cosials; Eike C Schulz; Lotte Lambertsen; Georgy Smyshlyaev; Carlos Rojas-Cordova; Kristoffer Forslund; Ezgi Karaca; Aleksandra Bebel; Peer Bork; Orsolya Barabas
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.